Bangalore, Karnataka, India:HealthCare Global Enterprises Limited, (HCG), the Specialist in Cancer Care, today announced that Temasek Holdings, a Singapore based investment company, has become a shareholder in the company.
Temasek joins existing investors, Premji Invest, an investment entity owned by Mr. Azim Premji, and Milestone Religare in a primary equity issuance by the Company. Evolvence India Life Sciences Fund, which has been an investor in HCG since 2007, will be exiting their investment to Temasek in the Company.
“We are happy to bring on board an equity partner of the stature of Temasek as we begin the next phase of growth. Temasek’s global perspective and long term interest in healthcare makes them a valuable partner. We also welcome Dr. Jennifer Lee to our board and look forward to benefiting from her vast experiences in health management and policy”, said Dr. B.S. Ajaikumar, Chairman and CEO of HCG Enterprises Ltd.
“We are pleased to have the opportunity to invest in HCG, who have redefined cancer care in India," said Rohit Sipahimalani, Head- India, Temasek Holdings.
About HCG Enterprises Ltd:
Health Care Global Enterprises Ltd, (HCG), The Specialist in Cancer Care, headquartered in Bangalore with over 26 centers is Asia’s largest cancer care network. HCG has defined the future of cancer care in India by designing, building and managing cancer care centers with a committed vision. HCG focuses on cancer care treatment, imaging and laboratory services, clinical trials and research services. The vision of HCG is to make high quality cancer care accessible by adopting global innovations to all segments of the society.
For more information on HCG, please visit www.hcgoncology.com
Incorporated in 1974, Temasek is an investment company based in Singapore, with 11 affiliates and offices in Asia and Latin America. Temasek owns a S$198 billion (US$157 billion) portfolio as at 31 March 2012, mainly in Singapore and Asia.
Temasek's investment themes centre on:
-- Transforming Economies
-- Growing Middle Income Populations
-- Deepening Comparative Advantages
-- Emerging Champions
Temasek’s portfolio covers a broad spectrum of industries: energy & resources; financial services; transportation, logistics and industrials; telecommunications, media & technology; life sciences and consumer & real estate.
Total shareholder return since inception in 1974 has been a healthy 17% compounded annually. The company has a corporate credit rating of AAA/Aaa by rating agencies Standard & Poor's and Moody's respectively.
For more information on Temasek, please visit www.temasek.com.sg
Satish Manjunath, Corporate Communications & Public Relations, Health Care Global Enterprises Ltd.(HCG), +91 9741237830